| You are here: Home: BCU 3|2001: Section 4: Select publications
Section 4
Aromatase Inhibitors in
Clinical Practice
Nabholtz JM
et al. Anastrozole Is Superior to Tamoxifen as First-Line Therapy
for Advanced Breast Cancer in Postmenopausal Women: Results of a
North American Multicenter Randomized Trial. J Clin Oncol
2000;18(22):3758-3767.
http://www.jco.org/cgi/content/abstract/18/22/3758
Bonneterre J et al. Anastrozole Versus Tamoxifen as First-Line
Therapy for Advanced
Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen
or Arimidex Randomized Group Efficacy and Tolerability Study.
J Clin
Oncol 2000;18(22):3748-3757.
http://www.jco.org/cgi/content/abstract/18/22/3748
|
